Supernus Pharmaceuticals
SUPN
#4516
Rank
A$2.65 B
Marketcap
$48.19
Share price
0.91%
Change (1 day)
10.32%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2023 (TTM): $1.17

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $1.18. In 2022 the company made an earnings per share (EPS) of $1.69 an increase over its 2021 EPS that were of $1.53.

EPS history for Supernus Pharmaceuticals from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$1.17-30.96%
2022$1.6910.78%
2021$1.53-57.68%
2020$3.6112.09%
2019$3.220.47%
2018$3.2189.38%
2017$1.69-38.59%
2016$2.76534.48%
2015$0.43-211.54%
2014-$0.39-91.1%
2013-$4.3839.46%
2012-$3.14-69.27%
2011-$10.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$28.98 2,345.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.14 587.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.95 402.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.46 276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.13 1,682.95%๐Ÿ‡บ๐Ÿ‡ธ USA